Icentia Receives U.S. Food and Drug Administration (FDA) Clearance for CardioSTAT®
(Adnkronos) – QUEBEC CITY, April 6, 2023 /PRNewswire/ — Icentia Inc., today announced that it has received FDA 510(k) clearance for CardioSTAT, an ambulatory, continuous ECG monitoring solution that relies on a
